JOHN HOPE FRANKLIN CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1838-01-01

Employees: 5K

Market Cap: -

Website: http://www.duke.edu

Clinical Trials

Effectiveness of a Vaccination Program in the Community Ob/Gyn Setting

Completed

Conditions: Influenza Vaccine
Papillomavirus Infection
Pertussis

First Posted Date: 2009-01-26

Last Posted Date: 2012-10-16

Lead Sponsor: Duke University

Target Recruit Count: 3988

Registration Number: NCT00828555

Locations: 🇺🇸
Atrium OBGYN, Raleigh, North Carolina, United States
🇺🇸
Blue Ridge OBGYN, Raleigh, North Carolina, United States
🇺🇸
Westside OBGYN, Burlington, North Carolina, United States

and more 1 locations

Lenalidomide and Decitabine in High Grade Myelodysplastic Syndromes

Phase 1

Completed

Conditions: Myelodysplastic Syndromes

Interventions: Drug: Lenalidomide, Decitabine

First Posted Date: 2009-01-26

Last Posted Date: 2013-09-09

Lead Sponsor: Duke University

Target Recruit Count: 15

Registration Number: NCT00828802

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Role of RhuMab-E25 in Reducing Exhaled Nitric Oxide (NO) in Allergic Asthma

Phase 3

Completed

Conditions: Allergic Asthma

First Posted Date: 2009-01-26

Last Posted Date: 2016-02-08

Lead Sponsor: Duke University

Target Recruit Count: 20

Registration Number: NCT00829179

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Validation of Brain Oxygenation Monitor

Not Applicable

Completed

Conditions: Healthy

Interventions: Device: Desaturation

First Posted Date: 2008-12-30

Last Posted Date: 2013-04-16

Lead Sponsor: Duke University

Target Recruit Count: 18

Registration Number: NCT00815490

Locations: 🇺🇸
Duke University Health System, Durham, North Carolina, United States

Study of Sorafenib/Cetuximab in Head and Neck Cancer

Phase 1

Completed

Conditions: Squamous Cell Cancer

Interventions: Drug: Sorafenib
Drug: Cetuximab

First Posted Date: 2008-12-30

Last Posted Date: 2014-12-08

Lead Sponsor: Duke University

Target Recruit Count: 31

Registration Number: NCT00815295

Locations: 🇺🇸
Duke University Health System, Durham, North Carolina, United States

Prevention and Treatment of Immersion Pulmonary Edema

Early Phase 1

Completed

Conditions: Immersion Pulmonary Edema (IPE)
Swimming Induced Pulmonary Edema (SIPE)

Interventions: Drug: Sildenafil

First Posted Date: 2008-12-30

Last Posted Date: 2016-01-26

Lead Sponsor: Duke University

Target Recruit Count: 10

Registration Number: NCT00815646

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Cholesterol, Hypertension and Glucose Education Study

Not Applicable

Completed

Conditions: Cardiovascular Disease
Diabetes

Interventions: Behavioral: Tailored cardiovascular risk management (Nurse-administered )

First Posted Date: 2008-12-30

Last Posted Date: 2023-11-15

Lead Sponsor: Duke University

Target Recruit Count: 362

Registration Number: NCT00815789

Locations: 🇺🇸
Duke University Health Care System, Durham, North Carolina, United States

Coping With High Grade Glioma

Not Applicable

Terminated

Conditions: Glioma

Interventions: Behavioral: coping skills intervention training
Behavioral: usual care

First Posted Date: 2008-12-29

Last Posted Date: 2013-05-06

Lead Sponsor: Duke University

Target Recruit Count: 14

Registration Number: NCT00815152

Locations: 🇺🇸
The Preston Robert Tisch Brain Tumor Center at Duke, Durham, North Carolina, United States

Myeloablative Allogeneic Stem Cell Transplantation Using a Naive T-Cell Depleted Peripheral Blood Stem Cell Graft

Phase 1

Terminated

Conditions: ANLL
ALL
NHL
MDS

Interventions: Procedure: Naive T-cell Depleted Stem Cell Transplant
Procedure: Stem Cell Transplant No Manipulation
Device: Isolex device from Baxter

First Posted Date: 2008-12-29

Last Posted Date: 2013-11-25

Lead Sponsor: Duke University

Target Recruit Count: 15

Registration Number: NCT00814983

Stereotactic Radiosurgery After Surgery in Treating Patients With Brain Metastases

Phase 2

Terminated

Conditions: Unspecified Adult Solid Tumor, Protocol Specific
Metastatic Cancer

Interventions: Behavioral: MMSE
Behavioral: QOL via FACT-Br
Procedure: MRI
Radiation: Post-operative SRS

First Posted Date: 2008-12-24

Last Posted Date: 2019-02-26

Lead Sponsor: Duke University

Target Recruit Count: 1

Registration Number: NCT00814463

Locations: 🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy